Sanofi-Aventis
The acquisition would “increase the value for both sets of shareholders, so I think it would be a shame to walk” Viehbacher said, “but again all options are on the table.
Monday, October 4, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment